We recently published a list of 10 Firms Crushing the Market. In this article, we are going to take a look at where Tempus AI ...

We recently published a list of Why These 10 Stocks Soared Today. In this article, we are going to take a look at where ...

Adjusted EBITDA improved significantly to $-16.2 million compared to $-43.9 million in Q1 2024, representing a $27.8 million ...

Tempus AI is gaining traction and on track for profits this year; high short interest and rising institutional activity point ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, has announced the presentation of six posters, including one oral ...

Tempus AI shares rose after a Q1 beat, as an analyst highlighted its AI-driven growth, expanding pharma deals, and $1B+ ...

Tempus AI reassured investors that its major pharma contracts remain strong despite funding and tariff pressures.

We’re winding down earnings season, and the old Wall Street adage that “earnings drive stock prices” continues to prove true.

Elizabeth Krutoholow; VP, Investor Relations; Tempus AI Inc. Jim Rogers; Chief Financial Officer; Tempus AI Inc. Eric Lefkofsky; Chief Executive Officer, Director; T ...

CompanyOverview|NASDAQ:TEM] Tempus AI (NASDAQ: TEM) is an interesting AI story that operates a platform and library for ...